Finance

Beta
Lists
VYYRF:OTCMKTS
Voyageur Pharmaceuticals Ltd
$0.014
0.00%
(0.00) 1D
Jun 3, 3:35:25 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VYYRF...
Mkt. cap
14.41M
Avg. vol.
2.22K
Volume
0.00
52-wk high
$0.24
52-wk low
$0.00
Beta
54.24
Shares outstanding
179.48M
Mkt. cap
14.41M
Avg. vol.
2.22K
Volume
0.00
52-wk high
$0.24
52-wk low
$0.00
Beta
54.24
Shares outstanding
179.48M
News stories
From sources across the web
About Voyageur Pharmaceuticals Ltd
CEO-
Employees-
Founded2008
HeadquartersCalgary, Alberta, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
-
11.04K
645.00
19.27K
Cost of goods sold
-
13.87K
-2.18K
19.27K
Cost of revenue
-
13.87K
-2.18K
19.27K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
272.86K
818.21K
716.41K
542.06K
Operating expense
374.93K
1.06M
788.06K
586.10K
Total operating expenses
374.93K
1.07M
785.88K
605.37K
Operating income
-374.93K
-1.06M
-785.23K
-586.10K
Other non operating income
-169.32K
-242.25K
-80.71K
-41.33K
EBT including unusual items
-544.26K
-1.30M
-865.95K
-627.42K
EBT excluding unusual items
-544.26K
-1.30M
-865.95K
-627.42K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-544.26K
-1.30M
-865.95K
-627.42K
Net profit margin
-
-11,818.80%
-134,255.19%
-3,255.28%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
283.00
283.00
283.00
283.00
EBITDA
-374.65K
-1.06M
-784.95K
-585.81K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more